Clinical TrialsSearch results
Number of results: 681
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment (MagnetisMM-9)
- relapsed/refractory multiple myeloma
- Kawai Norisuke
- 2021-10-11
Other
- Phase II Study of Docetaxel and TS-1 Combination Therapy for Outpatients with Relapsed or Refractory Non-small Cell Lung cancer
- Relapsed or Refractory Non-small Cell Lung Cancer
- Outpatient Oncology Unit Kyoto University Hospital
- 2006-10-12
Other
- A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IberDd) VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVd) IN SUBJECTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) (EXCALIBER-RRMM)
- Relapsed or refractory multiple myeloma (RRMM)
- Kimura Shunsuke
- 2021-07-01
Other
- A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination with Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
- Relapsed or Refractory Multiple Myeloma
- Nakama Takahiro
- 2022-10-07
Other
- A Phase 1, Open-label, Dose Finding Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Subjects with Relapsed and Refractory Multiple Myeloma
- Relapsed and refractory multiple myeloma
- Hayakawa Jin
- 2023-10-04
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Not yet recruiting
- Phase I/IIa clinical study of PAL-222 targeting patients with Refractory skin ulcer
- Refractory skin ulcers
- Kusano Hitoshi
- 2025-03-04